Returning for the seventh year, the 7th Antigen-Specific Immune Tolerance Summit (March 18 - 20, 2024 | Boston, MA) will lean into the industry’s key challenges from details of T-cell assays in […]

“The translational impact and nature of the work that was being presented were outstanding. You get a lot of insights from your peers regarding their experience interacting with the regulatory […]

The Definitive Industry Forum for CKD Drug Development Advance More Personalized Therapies for Rare & Common Kidney Diseases The 6th CKD Drug Development Summit is the definitive forum for KOLs, […]

In the dynamic cell therapy landscape, the challenge of potency assay development looms large, as exemplified by clinical holds experienced by Mesoblast and Verve Therapeutics in recent years. At the 3rd […]

Following the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of expanded access programs witnesses a critical rise. Back in […]

The 4ᵗʰ Wet AMD & Diabetic Eye Disease Drug Development Summit is returning to Boston this upcoming March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer […]

Step into the 2nd Targeted Intracellular Delivery Summit, a thrilling exploration of cutting-edge advancements in drug delivery. This year, we redefine possibilities, venturing beyond traditional boundaries with a focus on […]